Korean Journal of Clinical Oncology

Aims & Scope

The Korean Journal of Clinical Oncology (Korean J Clin Oncol, KJCO) is an official publication of the Korean Society of Surgical Oncology. KJCO serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. This journal aims to extend the lifespan and improve the quality of life for cancer patients through comprehensive research, not only focused on cancer treatment but also covering a broad range of cancer-related studies. Its scope includes a wide range of tumors, such as gastrointestinal, breast, head and neck cancers, soft tissue tumors, and tumors of other organs. To this end, KJCO welcomes submissions across a broad spectrum of topics within clinical oncology, including but not limited to: Cancer genetics and genomics Cancer metabolism and molecular oncology Cellular and immuno-oncology Epidemiology and cancer prevention Surgical oncology Radiotherapy and chemotherapy Palliative care and survivorship: supportive care and quality of life issues Precision medicine Clinical trials and novel therapeutic approaches Artificial Intelligence and Machine Learning in Oncology

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Subject Classification